Using a Wireless Controller to Deliver a Lighting Intervention to Persons With Dementia
MF
Overseen byMariana Figueiro, PhD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Icahn School of Medicine at Mount Sinai
No Placebo Group
Trial Summary
What is the purpose of this trial?
To test the effect of a tailored lighting intervention controlled by the Readings At Desk (RAD) controller on sleep and mood in Alzheimer's disease participants.
Research Team
MF
Mariana Figueiro, PhD
Principal Investigator
Mount Sinai Icahn School of Medicine
Eligibility Criteria
Inclusion Criteria
Diagnosis of Alzheimer's disease with a Mini Mental Score Examination (MMSE) between 0 and 19
You have severe sleep problems, as measured by a questionnaire called the PSQI, with a score higher than 5.
Exclusion Criteria
You are currently taking medication to help you sleep.
Treatment Details
Interventions
- Active lighting intervention (Behavioural Intervention)
- Control lighting intervention (Behavioural Intervention)
Participant Groups
2Treatment groups
Active Control
Group I: Active lighting intervention then Control lighting conditionActive Control2 Interventions
Each lighting condition will be 8 weeks in length. After a 4 week washout, each participant will crossover to the opposite condition.
Group II: Control lighting condition then Active light interventionActive Control2 Interventions
Each lighting condition will be 8 weeks in length. After a 4 week washout, each participant will crossover to the opposite condition.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Icahn School of Medicine at Mount Sinai
Lead Sponsor
Trials
933
Recruited
579,000+
Dr. Brendan Carr
Icahn School of Medicine at Mount Sinai
Chief Executive Officer since 2024
MD, MA, MS
Dr. Vicki LoPachin
Icahn School of Medicine at Mount Sinai
Chief Medical Officer
MD, FACP, MBA